|
Apr 11
|
2 Oversold Stocks Ready to Bounce Back and 1 to Approach with Caution
|
|
Apr 7
|
Immuno-Oncology Stocks Q4 Highlights: Incyte (NASDAQ:INCY)
|
|
Mar 28
|
High Growth Tech Stocks To Watch In The US March 2025
|
|
Mar 27
|
Should You Retain Exact Sciences Stock in Your Portfolio Now?
|
|
Mar 26
|
2 Small-Cap Stocks on Our Watchlist and 1 to Ignore
|
|
Mar 24
|
Why Exact Sciences Corporation (EXAS) is Among the Best Diagnostics Stocks to Invest in Right Now
|
|
Mar 21
|
Exact Sciences (EXAS) Down 10.6% Since Last Earnings Report: Can It Rebound?
|
|
Mar 20
|
1 Healthcare Stock on Our Watchlist and 2 to Turn Down
|
|
Mar 20
|
Should You Invest in Exact Sciences Corp. (EXAS)?
|
|
Mar 20
|
Natera (NASDAQ:NTRA) Q4 Earnings: Leading The Immuno-Oncology Pack
|
|
Mar 19
|
SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF JEFF ELLIOTT TO ITS BOARD; RYAN TRIMBLE AND MARCUS WILSON TO STEP DOWN
|
|
Feb 24
|
Exact Sciences to Participate in March Investor Conferences
|
|
Feb 21
|
Exact Sciences Full Year 2024 Earnings: EPS Misses Expectations
|
|
Feb 20
|
Why Exact Sciences (EXAS) Shares Are Trading Lower Today
|
|
Feb 20
|
Q4 2024 Exact Sciences Corp Earnings Call
|
|
Feb 20
|
EXAS Q4 Loss Narrower Than Expected, Stock Falls, Revenues Up Y/Y
|
|
Feb 20
|
Exact Sciences Corp (EXAS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...
|
|
Feb 20
|
Exact Sciences (EXAS) Q4 2024 Earnings Call Transcript
|
|
Feb 19
|
Exact Sciences (EXAS) Reports Q4 Loss, Tops Revenue Estimates
|
|
Feb 19
|
Exact Sciences: Q4 Earnings Snapshot
|